-
2
-
-
72249106244
-
Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder
-
10.1136/ebmh.11.4.111. 18952960
-
Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder. A Cleare, Evid Based Ment Health 2008 11 111 10.1136/ebmh.11.4.111 18952960
-
(2008)
Evid Based Ment Health
, vol.11
, pp. 111
-
-
Cleare, A.1
-
3
-
-
21744436533
-
Treatment of acute mania with aripiprazole in an older adult with noted improvement in coexisting parkinson's disease
-
10.4088/PCC.v06n0112. 15486603
-
Treatment of acute mania with aripiprazole in an older adult with noted improvement in coexisting parkinson's disease. S Gupta M Chohan S Madhusoodanan, Prim Care Companion J Clin Psychiatry 2004 6 50 51 10.4088/PCC.v06n0112 15486603
-
(2004)
Prim Care Companion J Clin Psychiatry
, vol.6
, pp. 50-51
-
-
Gupta, S.1
Chohan, M.2
Madhusoodanan, S.3
-
4
-
-
1442300056
-
Aripiprazole for drug-induced psychosis in parkinson disease: Preliminary experience
-
10.1097/00002826-200401000-00003. 15090928
-
Aripiprazole for drug-induced psychosis in parkinson disease: preliminary experience. HH Fernandez ME Trieschmann JH Friedman, Clin Neuropharmacol 2004 27 4 5 10.1097/00002826-200401000-00003 15090928
-
(2004)
Clin Neuropharmacol
, vol.27
, pp. 4-5
-
-
Fernandez, H.H.1
Trieschmann, M.E.2
Friedman, J.H.3
-
5
-
-
0029197942
-
Role of serotonin in the action of atypical antipsychotic drugs
-
7583621
-
Role of serotonin in the action of atypical antipsychotic drugs. HY Meltzer, Clin Neurosci 1995 3 64 75 7583621
-
(1995)
Clin Neurosci
, vol.3
, pp. 64-75
-
-
Meltzer, H.Y.1
-
6
-
-
33846427359
-
EPS profiles: The atypical antipsychotics are not all the same
-
10.1097/00131746-200701000-00003. 17242588
-
EPS profiles: the atypical antipsychotics are not all the same. PJ Weiden, J Psychiatr Pract 2007 13 13 24 10.1097/00131746-200701000-00003 17242588
-
(2007)
J Psychiatr Pract
, vol.13
, pp. 13-24
-
-
Weiden, P.J.1
-
7
-
-
33846447413
-
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with parkinson's disease
-
10.1002/mds.21091. 17013906
-
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with parkinson's disease. JH Friedman RM Berman CG Goetz SA Factor WG Ondo J Wojcieszek WH Carson RN Marcus, Mov Disord 2006 21 2078 2081 10.1002/mds.21091 17013906
-
(2006)
Mov Disord
, vol.21
, pp. 2078-2081
-
-
Friedman, J.H.1
Berman, R.M.2
Goetz, C.G.3
Factor, S.A.4
Ondo, W.G.5
Wojcieszek, J.6
Carson, W.H.7
Marcus, R.N.8
-
8
-
-
38049071118
-
Increased use of second generation antipsychotic drugs in primary care: Potential relevance for hospitalizations in schizophrenia patients
-
10.1007/s00228-007-0386-1. 17952424
-
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients. MC Caceres EM Penas-Lledo A de la Rubia A Llerena, Eur J Clin Pharmacol 2008 64 73 76 10.1007/s00228-007-0386-1 17952424
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 73-76
-
-
Caceres, M.C.1
Penas-Lledo, E.M.2
De La Rubia, A.3
Llerena, A.4
-
9
-
-
27144556090
-
Psychosis in parkinson's disease
-
10.1136/pgmj.2004.032029. 16210460
-
Psychosis in parkinson's disease. BR Thanvi TC Lo DP Harsh, Postgrad Med J 2005 81 644 646 10.1136/pgmj.2004.032029 16210460
-
(2005)
Postgrad Med J
, vol.81
, pp. 644-646
-
-
Thanvi, B.R.1
Lo, T.C.2
Harsh, D.P.3
-
10
-
-
72249091101
-
The relationship between exposure to aripiprazole and development of parkinsonism [abstract]
-
17465637
-
The relationship between exposure to aripiprazole and development of parkinsonism [abstract]. LL Lua L Zhang, Mov Disord 2008 23 80 17465637
-
(2008)
Mov Disord
, vol.23
, pp. 1980
-
-
Lua, L.L.1
Zhang, L.2
|